1900 Wealth Management LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

1900 Wealth Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 388 shares of the healthcare conglomerate’s stock, valued at approximately $203,000.

Other institutional investors have also recently bought and sold shares of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on UNH shares. Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. JPMorgan Chase & Co. reduced their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a research report on Thursday, May 15th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday, June 3rd. Robert W. Baird lowered shares of UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 price target for the company. in a research report on Wednesday, June 11th. Finally, TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a research report on Monday, May 19th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $426.52.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $307.84 on Tuesday. The company has a 50 day moving average of $381.74 and a 200 day moving average of $470.20. The stock has a market cap of $279.25 billion, a P/E ratio of 19.86, a P/E/G ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the firm posted $6.91 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.87%. UnitedHealth Group’s payout ratio is presently 37.02%.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director John H. Noseworthy acquired 300 shares of the stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 over the last three months. 0.28% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.